Bio-Rad Laboratories, Inc. (BIO)
369.95
+6.45
(+1.77%)
USD |
NYSE |
Oct 23, 16:00
370.15
+0.20
(+0.05%)
After-Hours: 20:00
Bio-Rad Laboratories Enterprise Value : 9.642B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 9.642B |
| October 22, 2026 | 9.470B |
| October 21, 2026 | 9.389B |
| October 20, 2026 | 9.229B |
| October 19, 2026 | 9.184B |
| October 16, 2026 | 9.208B |
| October 15, 2026 | 9.505B |
| October 14, 2026 | 9.441B |
| October 13, 2026 | 9.476B |
| October 12, 2026 | 9.494B |
| October 09, 2026 | 9.541B |
| October 08, 2026 | 9.387B |
| October 07, 2026 | 9.588B |
| October 06, 2026 | 9.612B |
| October 05, 2026 | 9.906B |
| October 02, 2026 | 9.620B |
| October 01, 2026 | 9.258B |
| September 30, 2026 | 9.850B |
| September 29, 2026 | 9.899B |
| September 28, 2026 | 9.849B |
| September 25, 2026 | 9.937B |
| September 24, 2026 | 10.11B |
| September 23, 2026 | 9.881B |
| September 22, 2026 | 9.899B |
| September 21, 2026 | 9.839B |
| Date | Value |
|---|---|
| September 18, 2026 | 9.815B |
| September 17, 2026 | 9.975B |
| September 16, 2026 | 9.885B |
| September 15, 2026 | 9.857B |
| September 14, 2026 | 9.605B |
| September 11, 2026 | 9.625B |
| September 10, 2026 | 9.610B |
| September 09, 2026 | 9.830B |
| September 08, 2026 | 9.914B |
| September 04, 2026 | 10.07B |
| September 03, 2026 | 10.12B |
| September 02, 2026 | 10.14B |
| September 01, 2026 | 9.936B |
| August 31, 2026 | 10.07B |
| August 28, 2026 | 10.12B |
| August 27, 2026 | 10.18B |
| August 26, 2026 | 10.14B |
| August 25, 2026 | 10.19B |
| August 24, 2026 | 9.958B |
| August 21, 2026 | 9.912B |
| August 20, 2026 | 9.816B |
| August 19, 2026 | 9.490B |
| August 18, 2026 | 9.181B |
| August 17, 2026 | 9.248B |
| August 14, 2026 | 9.276B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Thermo Fisher Scientific, Inc. | 284.58B |
| Danaher Corp. | 184.25B |
| Agilent Technologies, Inc. | 50.99B |
| Illumina, Inc. | 42.04B |
| Revvity, Inc. | 20.03B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 371.40M |
| Revenue (Quarterly) | 651.00M |
| Total Expenses (Quarterly) | 279.60M |
| EPS Diluted (Quarterly) | 13.85 |
| Gross Profit Margin (Quarterly) | 53.12% |
| Profit Margin (Quarterly) | 57.05% |
| Earnings Yield | 2.23% |
| Operating Earnings Yield | 2.36% |
| Normalized Earnings Yield | 1.734 |